PerkinElmer (NYSE: [[ticker:PKI]]), the maker of scientific instruments based in Waltham, MA, said today it has agreed to acquire Spokane, WA-based Signature Genomic Laboratories for about $90 million in cash, according to a regulatory filing. The move will enable PerkinElmer to strengthen its genetic testing services and expand into molecular diagnostics, particularly cancer diagnostics, according to a statement. Signature has about 120 employees.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
